Loading…

Perspectives and Misconceptions of an Online Adult Male Cohort Regarding Prostate Cancer Screening

Congruent with most guideline publishers, the Canadian Urological Association (CUA) recommends shared decision-making (SDM) on PSA screening (PSAS) for prostate cancer (PCa) following a discussion of its benefits and harms. However, there are limited data on how the general male population feels abo...

Full description

Saved in:
Bibliographic Details
Published in:Current oncology (Toronto) 2024-10, Vol.31 (10), p.6395-6405
Main Authors: Sheetz, Tyler, Posid, Tasha, Khuhro, Aliza, Scimeca, Alicia, Beebe, Sarah, Gul, Essa, Dason, Shawn
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c415t-92ec6d9aaee73d1650996fcf62f31d23f70c10d1cf34445536a5f367520ebd953
container_end_page 6405
container_issue 10
container_start_page 6395
container_title Current oncology (Toronto)
container_volume 31
creator Sheetz, Tyler
Posid, Tasha
Khuhro, Aliza
Scimeca, Alicia
Beebe, Sarah
Gul, Essa
Dason, Shawn
description Congruent with most guideline publishers, the Canadian Urological Association (CUA) recommends shared decision-making (SDM) on PSA screening (PSAS) for prostate cancer (PCa) following a discussion of its benefits and harms. However, there are limited data on how the general male population feels about these topics. A survey was completed by 906 male-identifying participants (age > 18) recruited via Amazon Mechanical Turk (MTurk), which is a crowdsourcing platform providing minimal compensation. Participants answered questions regarding demographics (15), personal/family history (9), PCa/PSA knowledge (41), and opinions regarding PSAS (45). The median age was 38.2 (SD = 12.0), with 22% reporting a family history of PCa and 20% reporting personally undergoing PSAS. Although most participants had heard of PCa (85%) and that they could be screened for it (81%), they generally did not feel knowledgeable about PCa or PSAS guidelines. Most want to talk to their clinician about PCa and PSAS (74%) and are supportive of SDM (48%) or patient-centered decision-making (25%). In general, participants thought PSAS was still worthwhile, even if it led to additional testing or side effects. Similarly, participants thought higher-risk patients should be screened earlier ( < 0.001). A number of misconceptions were evident in the responses. Men approaching the age of PSAS do not feel knowledgeable about PCa or PSAS and want their clinician to discuss these topics with them. The majority believe in PSAS and would like to undergo this screening following SDM. Clinicians also have a role in correcting common misconceptions about PCa.
doi_str_mv 10.3390/curroncol31100475
format article
fullrecord <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_8a47c58e8bd1473f857a144ac344d525</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A814095788</galeid><doaj_id>oai_doaj_org_article_8a47c58e8bd1473f857a144ac344d525</doaj_id><sourcerecordid>A814095788</sourcerecordid><originalsourceid>FETCH-LOGICAL-c415t-92ec6d9aaee73d1650996fcf62f31d23f70c10d1cf34445536a5f367520ebd953</originalsourceid><addsrcrecordid>eNptkt9vFCEQxzdGY2v1D_DFkPjiy1VmgWV5MpeLrU3atPHHM-Fg2NLswQm7Tfzv5bza9KLhATLz_X4yzEzTvAV6ypiiH-2cc4o2jQyAUi7Fs-YYJPQLKVv1_Mn7qHlVyh2ljEkpXzZHTHEBUqrjZn2DuWzRTuEeCzHRkatQbIXidgopFpJ8jZLrOIaIZOnmcSJXZkSySrcpT-QrDia7EAdyk1OZzFQzproz-WYzYqyZ180Lb8aCbx7uk-bH2efvqy-Ly-vzi9XycmE5iGmhWrSdU8YgSuagE1SpzlvftZ6Ba5mX1AJ1YD3jnAvBOiM866RoKa6dEuykudhzXTJ3epvDxuRfOpmg_wRSHrTJU7Aj6t5waUWP_doBl8z3Qhrg3NiKdqLdsT7tWdt5vUFnMU7ZjAfQw0wMt3pI9xpA0K4DVgkfHgg5_ZyxTHpTG4vjaCKmuWgGLRWq76Gv0vd76VAbq0P0qSLtTq6XPXCqhOx3qtP_qOpxuAl1YuhDjR8YYG-wdTIlo38sH6je7Y_-Z3-q593Tfz86_i4M-w2F1sLl</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3120598818</pqid></control><display><type>article</type><title>Perspectives and Misconceptions of an Online Adult Male Cohort Regarding Prostate Cancer Screening</title><source>PubMed (Medline)</source><creator>Sheetz, Tyler ; Posid, Tasha ; Khuhro, Aliza ; Scimeca, Alicia ; Beebe, Sarah ; Gul, Essa ; Dason, Shawn</creator><creatorcontrib>Sheetz, Tyler ; Posid, Tasha ; Khuhro, Aliza ; Scimeca, Alicia ; Beebe, Sarah ; Gul, Essa ; Dason, Shawn</creatorcontrib><description>Congruent with most guideline publishers, the Canadian Urological Association (CUA) recommends shared decision-making (SDM) on PSA screening (PSAS) for prostate cancer (PCa) following a discussion of its benefits and harms. However, there are limited data on how the general male population feels about these topics. A survey was completed by 906 male-identifying participants (age &gt; 18) recruited via Amazon Mechanical Turk (MTurk), which is a crowdsourcing platform providing minimal compensation. Participants answered questions regarding demographics (15), personal/family history (9), PCa/PSA knowledge (41), and opinions regarding PSAS (45). The median age was 38.2 (SD = 12.0), with 22% reporting a family history of PCa and 20% reporting personally undergoing PSAS. Although most participants had heard of PCa (85%) and that they could be screened for it (81%), they generally did not feel knowledgeable about PCa or PSAS guidelines. Most want to talk to their clinician about PCa and PSAS (74%) and are supportive of SDM (48%) or patient-centered decision-making (25%). In general, participants thought PSAS was still worthwhile, even if it led to additional testing or side effects. Similarly, participants thought higher-risk patients should be screened earlier ( &lt; 0.001). A number of misconceptions were evident in the responses. Men approaching the age of PSAS do not feel knowledgeable about PCa or PSAS and want their clinician to discuss these topics with them. The majority believe in PSAS and would like to undergo this screening following SDM. Clinicians also have a role in correcting common misconceptions about PCa.</description><identifier>ISSN: 1718-7729</identifier><identifier>ISSN: 1198-0052</identifier><identifier>EISSN: 1718-7729</identifier><identifier>DOI: 10.3390/curroncol31100475</identifier><identifier>PMID: 39451779</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>Adult ; Adults ; Aged ; Cancer ; Cohort Studies ; CUA guidelines ; Diagnosis ; Early Detection of Cancer - methods ; Health Knowledge, Attitudes, Practice ; Humans ; Male ; Middle Aged ; Prostate cancer ; Prostate-Specific Antigen - blood ; Prostatic Neoplasms - diagnosis ; PSA ; PSA screening ; Surveys ; Surveys and Questionnaires ; USPSTF</subject><ispartof>Current oncology (Toronto), 2024-10, Vol.31 (10), p.6395-6405</ispartof><rights>COPYRIGHT 2024 MDPI AG</rights><rights>2024 by the authors. 2024</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c415t-92ec6d9aaee73d1650996fcf62f31d23f70c10d1cf34445536a5f367520ebd953</cites><orcidid>0000-0002-4440-1477</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11506613/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11506613/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39451779$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sheetz, Tyler</creatorcontrib><creatorcontrib>Posid, Tasha</creatorcontrib><creatorcontrib>Khuhro, Aliza</creatorcontrib><creatorcontrib>Scimeca, Alicia</creatorcontrib><creatorcontrib>Beebe, Sarah</creatorcontrib><creatorcontrib>Gul, Essa</creatorcontrib><creatorcontrib>Dason, Shawn</creatorcontrib><title>Perspectives and Misconceptions of an Online Adult Male Cohort Regarding Prostate Cancer Screening</title><title>Current oncology (Toronto)</title><addtitle>Curr Oncol</addtitle><description>Congruent with most guideline publishers, the Canadian Urological Association (CUA) recommends shared decision-making (SDM) on PSA screening (PSAS) for prostate cancer (PCa) following a discussion of its benefits and harms. However, there are limited data on how the general male population feels about these topics. A survey was completed by 906 male-identifying participants (age &gt; 18) recruited via Amazon Mechanical Turk (MTurk), which is a crowdsourcing platform providing minimal compensation. Participants answered questions regarding demographics (15), personal/family history (9), PCa/PSA knowledge (41), and opinions regarding PSAS (45). The median age was 38.2 (SD = 12.0), with 22% reporting a family history of PCa and 20% reporting personally undergoing PSAS. Although most participants had heard of PCa (85%) and that they could be screened for it (81%), they generally did not feel knowledgeable about PCa or PSAS guidelines. Most want to talk to their clinician about PCa and PSAS (74%) and are supportive of SDM (48%) or patient-centered decision-making (25%). In general, participants thought PSAS was still worthwhile, even if it led to additional testing or side effects. Similarly, participants thought higher-risk patients should be screened earlier ( &lt; 0.001). A number of misconceptions were evident in the responses. Men approaching the age of PSAS do not feel knowledgeable about PCa or PSAS and want their clinician to discuss these topics with them. The majority believe in PSAS and would like to undergo this screening following SDM. Clinicians also have a role in correcting common misconceptions about PCa.</description><subject>Adult</subject><subject>Adults</subject><subject>Aged</subject><subject>Cancer</subject><subject>Cohort Studies</subject><subject>CUA guidelines</subject><subject>Diagnosis</subject><subject>Early Detection of Cancer - methods</subject><subject>Health Knowledge, Attitudes, Practice</subject><subject>Humans</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Prostate cancer</subject><subject>Prostate-Specific Antigen - blood</subject><subject>Prostatic Neoplasms - diagnosis</subject><subject>PSA</subject><subject>PSA screening</subject><subject>Surveys</subject><subject>Surveys and Questionnaires</subject><subject>USPSTF</subject><issn>1718-7729</issn><issn>1198-0052</issn><issn>1718-7729</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNptkt9vFCEQxzdGY2v1D_DFkPjiy1VmgWV5MpeLrU3atPHHM-Fg2NLswQm7Tfzv5bza9KLhATLz_X4yzEzTvAV6ypiiH-2cc4o2jQyAUi7Fs-YYJPQLKVv1_Mn7qHlVyh2ljEkpXzZHTHEBUqrjZn2DuWzRTuEeCzHRkatQbIXidgopFpJ8jZLrOIaIZOnmcSJXZkSySrcpT-QrDia7EAdyk1OZzFQzproz-WYzYqyZ180Lb8aCbx7uk-bH2efvqy-Ly-vzi9XycmE5iGmhWrSdU8YgSuagE1SpzlvftZ6Ba5mX1AJ1YD3jnAvBOiM866RoKa6dEuykudhzXTJ3epvDxuRfOpmg_wRSHrTJU7Aj6t5waUWP_doBl8z3Qhrg3NiKdqLdsT7tWdt5vUFnMU7ZjAfQw0wMt3pI9xpA0K4DVgkfHgg5_ZyxTHpTG4vjaCKmuWgGLRWq76Gv0vd76VAbq0P0qSLtTq6XPXCqhOx3qtP_qOpxuAl1YuhDjR8YYG-wdTIlo38sH6je7Y_-Z3-q593Tfz86_i4M-w2F1sLl</recordid><startdate>20241020</startdate><enddate>20241020</enddate><creator>Sheetz, Tyler</creator><creator>Posid, Tasha</creator><creator>Khuhro, Aliza</creator><creator>Scimeca, Alicia</creator><creator>Beebe, Sarah</creator><creator>Gul, Essa</creator><creator>Dason, Shawn</creator><general>MDPI AG</general><general>MDPI</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-4440-1477</orcidid></search><sort><creationdate>20241020</creationdate><title>Perspectives and Misconceptions of an Online Adult Male Cohort Regarding Prostate Cancer Screening</title><author>Sheetz, Tyler ; Posid, Tasha ; Khuhro, Aliza ; Scimeca, Alicia ; Beebe, Sarah ; Gul, Essa ; Dason, Shawn</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c415t-92ec6d9aaee73d1650996fcf62f31d23f70c10d1cf34445536a5f367520ebd953</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Adult</topic><topic>Adults</topic><topic>Aged</topic><topic>Cancer</topic><topic>Cohort Studies</topic><topic>CUA guidelines</topic><topic>Diagnosis</topic><topic>Early Detection of Cancer - methods</topic><topic>Health Knowledge, Attitudes, Practice</topic><topic>Humans</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Prostate cancer</topic><topic>Prostate-Specific Antigen - blood</topic><topic>Prostatic Neoplasms - diagnosis</topic><topic>PSA</topic><topic>PSA screening</topic><topic>Surveys</topic><topic>Surveys and Questionnaires</topic><topic>USPSTF</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sheetz, Tyler</creatorcontrib><creatorcontrib>Posid, Tasha</creatorcontrib><creatorcontrib>Khuhro, Aliza</creatorcontrib><creatorcontrib>Scimeca, Alicia</creatorcontrib><creatorcontrib>Beebe, Sarah</creatorcontrib><creatorcontrib>Gul, Essa</creatorcontrib><creatorcontrib>Dason, Shawn</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Directory of Open Access Journals</collection><jtitle>Current oncology (Toronto)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sheetz, Tyler</au><au>Posid, Tasha</au><au>Khuhro, Aliza</au><au>Scimeca, Alicia</au><au>Beebe, Sarah</au><au>Gul, Essa</au><au>Dason, Shawn</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Perspectives and Misconceptions of an Online Adult Male Cohort Regarding Prostate Cancer Screening</atitle><jtitle>Current oncology (Toronto)</jtitle><addtitle>Curr Oncol</addtitle><date>2024-10-20</date><risdate>2024</risdate><volume>31</volume><issue>10</issue><spage>6395</spage><epage>6405</epage><pages>6395-6405</pages><issn>1718-7729</issn><issn>1198-0052</issn><eissn>1718-7729</eissn><abstract>Congruent with most guideline publishers, the Canadian Urological Association (CUA) recommends shared decision-making (SDM) on PSA screening (PSAS) for prostate cancer (PCa) following a discussion of its benefits and harms. However, there are limited data on how the general male population feels about these topics. A survey was completed by 906 male-identifying participants (age &gt; 18) recruited via Amazon Mechanical Turk (MTurk), which is a crowdsourcing platform providing minimal compensation. Participants answered questions regarding demographics (15), personal/family history (9), PCa/PSA knowledge (41), and opinions regarding PSAS (45). The median age was 38.2 (SD = 12.0), with 22% reporting a family history of PCa and 20% reporting personally undergoing PSAS. Although most participants had heard of PCa (85%) and that they could be screened for it (81%), they generally did not feel knowledgeable about PCa or PSAS guidelines. Most want to talk to their clinician about PCa and PSAS (74%) and are supportive of SDM (48%) or patient-centered decision-making (25%). In general, participants thought PSAS was still worthwhile, even if it led to additional testing or side effects. Similarly, participants thought higher-risk patients should be screened earlier ( &lt; 0.001). A number of misconceptions were evident in the responses. Men approaching the age of PSAS do not feel knowledgeable about PCa or PSAS and want their clinician to discuss these topics with them. The majority believe in PSAS and would like to undergo this screening following SDM. Clinicians also have a role in correcting common misconceptions about PCa.</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>39451779</pmid><doi>10.3390/curroncol31100475</doi><tpages>11</tpages><orcidid>https://orcid.org/0000-0002-4440-1477</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1718-7729
ispartof Current oncology (Toronto), 2024-10, Vol.31 (10), p.6395-6405
issn 1718-7729
1198-0052
1718-7729
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_8a47c58e8bd1473f857a144ac344d525
source PubMed (Medline)
subjects Adult
Adults
Aged
Cancer
Cohort Studies
CUA guidelines
Diagnosis
Early Detection of Cancer - methods
Health Knowledge, Attitudes, Practice
Humans
Male
Middle Aged
Prostate cancer
Prostate-Specific Antigen - blood
Prostatic Neoplasms - diagnosis
PSA
PSA screening
Surveys
Surveys and Questionnaires
USPSTF
title Perspectives and Misconceptions of an Online Adult Male Cohort Regarding Prostate Cancer Screening
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T19%3A36%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Perspectives%20and%20Misconceptions%20of%20an%20Online%20Adult%20Male%20Cohort%20Regarding%20Prostate%20Cancer%20Screening&rft.jtitle=Current%20oncology%20(Toronto)&rft.au=Sheetz,%20Tyler&rft.date=2024-10-20&rft.volume=31&rft.issue=10&rft.spage=6395&rft.epage=6405&rft.pages=6395-6405&rft.issn=1718-7729&rft.eissn=1718-7729&rft_id=info:doi/10.3390/curroncol31100475&rft_dat=%3Cgale_doaj_%3EA814095788%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c415t-92ec6d9aaee73d1650996fcf62f31d23f70c10d1cf34445536a5f367520ebd953%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3120598818&rft_id=info:pmid/39451779&rft_galeid=A814095788&rfr_iscdi=true